1. Stocks
  2. Ajanta Pharma Ltd.
  3. Swot
swot-logo

Ajanta Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Ajanta Pharma Ltd. has 25 Strengths, 5 Weaknesses, 6 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Stocks gaining versus previous close, open price and RSI

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Increasing Revenue every Quarter for the past 4 Quarters

Increasing profits every quarter for the past 3 quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Near 52 Week High

RSI indicating price strength

Top Gainers

Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Promoters increased pledged shares QoQ

PEG greater than Industry PEG

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

High promoter stock pledges

Highest increase in pledges by promoters

Broker price or reco upgrades in last month

Brokers upgraded recommendation or target price in the past three months

Broker Upgrades: Stocks where brokers upgraded recommendation or price target in the past one month

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Broker price or reco upgrades in last month

Companies with high market cap, lower public shareholding

Rising Delivery Percentage Compared to Prev Day

Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks